Kolexia
De Percin Sixtine Oncologie médicale
De Percin Sixtine
Oncologie médicale
Hôpital Cochin
Paris, France
52 Activités
11 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Carcinomes Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Tumeurs du poumon Tumeurs de l'endomètre Tumeurs osseuses Néphrocarcinome Instabilité des microsatellites

Collaborateurs

Voir plus
Alexandre Jerome
Alexandre Jerome
Cabinet libéral, Paris, France
Boudou-Rouquette Pascaline
Boudou-Rouquette Pascaline
Hôpital Cochin, Paris, France
Goldwasser Francois
Goldwasser Francois
Hôpital Cochin, Paris, France
Akla Sarra
Akla Sarra
Centre hospitalier de Versailles, Le Chesnay, France

Industries

Voir plus
Amgen
8 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2021
Boehringer Ingelheim
2 collaboration(s)
Dernière en 2023
GSK
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Pharmacokinetic drug-drug interaction between olaparib and apixaban: a case report.
Cancer chemotherapy and pharmacology   03 novembre 2023
815P Clinical outcome of metastatic endometrial carcinoma patients treated with chemotherapy: ENDOVIE, a GINECO national observational cohort study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.
Cancer chemotherapy and pharmacology   24 août 2023
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
International journal of molecular sciences   10 janvier 2023
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Gynecologic oncology   13 décembre 2022
1073P Relationship between basal metabolism, nivolumab clearance and survival in metastatic non-small cell lung cancer patients of the ELY study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab.
Cancers   30 juin 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients.
Pharmaceutics   09 juin 2022
RIMEC: Assessment of Metabolic and Immune Profiles in Patients Receiving Immune Checkpoint Inhibitors (ICI) for Advanced Renal Cell Carcinoma or Lung Carcinoma.
Essai Clinique (Assistance publique – Hôpitaux de Paris)   15 novembre 2021
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study.
EBioMedicine   20 octobre 2021